San Diego, U.S.A.: Roche today announced positive results of the Phase III REFLEX study, evaluating the efficacy and safety of MabThera in patients with rheumatoid arthritis (RA), who have had an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results